Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Immunoassays
Antibody titer levels associated with protection against Omicron: Study
Immunoglobin G and neutralizing antibody titer levels were associated with protection against infection with the Omicron variant and against symptomatic disease.
May 23, 2023
Beckman Coulter analyzer developed 'from the ground up' to address IVD industry constraints
At a time of scarce resources, the system requires no daily maintenance and only 10 minutes weekly and monthly maintenance, said Dr. Pamela Christudoss of Christian Medical College, who evaluated the analyzer prior to its broad launch last week.
May 23, 2023
Thermo Fisher Scientific obtains FDA clearance for preeclampsia risk immunoassays
The new assays are the first and only such immunoassays to receive breakthrough designation and clearance for preeclampsia risk assessment and management, the company noted in a statement.
May 19, 2023
Zymo Research, Burst Diagnostics partner to develop, commercialize hand-held diagnostic testing platform
The device leverages a microfluidic cartridge that miniaturizes and integrates steps typically performed in the clinical laboratory setting, including washing and signal amplification, Zymo Research said.
May 18, 2023
Running stool test twice increases colon cancer detection rate in clinical trial
The fecal immunochemical test can deliver false negatives that may delay further investigations and the diagnosis and treatment of colorectal cancer. To try to raise the sensitivity, researchers explored the effects of testing twice.
May 18, 2023
At WorldLab-EuroMedLab 2023, Roche to demonstrate next-gen Dx, mass spec for routine testing
The company will unveil the Cobas Mass Spec system prototype, which aims to bring mass spectrometry to routine testing and complement the serum work area testing portfolio.
May 17, 2023
Peptide-based diagnostic testing shows promise in the monitoring of inflammatory diseases
Switching from antibodies to peptides may address testing challenges. Peptides, sequences of up to 50 amino acids, bind to proteins with high affinity and selectivity, making them suitable for use in lateral flow tests.
May 17, 2023
Beckman Coulter Diagnostics announces global launch of immunoassay analyzer
The analyzer can run up to 215 tests per hour per square meter and, according to Beckman Coulter Diagnostics, beta users attest to a feature that redefines their workday with no daily maintenance requirements.
May 15, 2023
OraSure Technologies Q1 revenues up 129% on COVID-19 rapid immunoassay sales
Demand for rapid tests is tapering, and OraSure is scaling-down COVID-19 test manufacturing amid staff layoffs.
May 11, 2023
AACC releases guidance on procalcitonin testing for patients with bacterial infections
Procalcitonin tests have been used for many years in Europe, but only became available in the U.S. in 2017, when the FDA approved them as tools to help guide antibiotic treatment, among other uses.
May 5, 2023
Meridian Bioscience receives FDA clearance for Shiga toxin assay
Meridian Bioscience is expanding its foodborne immunofluorescent test offering by adding Shiga toxin to the Curian platform.
April 20, 2023
Renalytix announces review data on kidney disease risk assessment test
A review of the data underscored the effectiveness of KidneyIntelX in identifying patients at greatest risk of decline into kidney failure at the earlier stages, when progression can be slowed.
April 19, 2023
Page 1 of 60
Next Page
